Cargando…

Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients

Introduction: The study aims to determine an association between presenting symptoms in multiple sclerosis and measures of disease severity, including the expanded disability status score (EDSS) and MRI based lesion volumes. Methods: Data was collected as part of a larger 3 year MS study, from 2014...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledesma, Jason, Puttagunta, Padma Priya, Torabi, Shayan, Berube, Kristen, Tamrazian, Eric, Garcia, Diamond, Mehta, Bijal Kirit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838821/
https://www.ncbi.nlm.nih.gov/pubmed/33430058
http://dx.doi.org/10.3390/neurolint13010002
_version_ 1783643270458376192
author Ledesma, Jason
Puttagunta, Padma Priya
Torabi, Shayan
Berube, Kristen
Tamrazian, Eric
Garcia, Diamond
Mehta, Bijal Kirit
author_facet Ledesma, Jason
Puttagunta, Padma Priya
Torabi, Shayan
Berube, Kristen
Tamrazian, Eric
Garcia, Diamond
Mehta, Bijal Kirit
author_sort Ledesma, Jason
collection PubMed
description Introduction: The study aims to determine an association between presenting symptoms in multiple sclerosis and measures of disease severity, including the expanded disability status score (EDSS) and MRI based lesion volumes. Methods: Data was collected as part of a larger 3 year MS study, from 2014 to 2017, to compare Vitamin A levels and MS progression. All data was collected from a single clinical site. Demographic data as well as date of diagnosis and use of disease modifying therapies. Patients not able to obtain MRIs or lab tests and histories of vitamin abnormalities were excluded from the study. 29 patients met inclusion criteria. We chose presenting symptoms of vision, balance, sensory function, and motor function as these represented the most common manifestations of the disease and mirror the domains of the EDSS, which is the most commonly used scale for MS disease severity. We also included neuroimaging based lesion volume as another objective measure for comparison. Results: Although duration of disease was different between comparator groups, no significant difference was found between them when EDSS and lesion volumes were compared. There was a difference in lesion volumes when comparing those patients that had presenting symptoms of visual changes or balance symptoms with those presenting with sensory changes. Conclusions: This study supports the notion that presenting symptoms are not associated with EDSS independent disease duration. It also verifies that severity of disease is not associated with lesion volumes. However, sensory symptoms as a presenting symptom was associated with less lesion volumes in our study.
format Online
Article
Text
id pubmed-7838821
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78388212021-01-28 Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients Ledesma, Jason Puttagunta, Padma Priya Torabi, Shayan Berube, Kristen Tamrazian, Eric Garcia, Diamond Mehta, Bijal Kirit Neurol Int Communication Introduction: The study aims to determine an association between presenting symptoms in multiple sclerosis and measures of disease severity, including the expanded disability status score (EDSS) and MRI based lesion volumes. Methods: Data was collected as part of a larger 3 year MS study, from 2014 to 2017, to compare Vitamin A levels and MS progression. All data was collected from a single clinical site. Demographic data as well as date of diagnosis and use of disease modifying therapies. Patients not able to obtain MRIs or lab tests and histories of vitamin abnormalities were excluded from the study. 29 patients met inclusion criteria. We chose presenting symptoms of vision, balance, sensory function, and motor function as these represented the most common manifestations of the disease and mirror the domains of the EDSS, which is the most commonly used scale for MS disease severity. We also included neuroimaging based lesion volume as another objective measure for comparison. Results: Although duration of disease was different between comparator groups, no significant difference was found between them when EDSS and lesion volumes were compared. There was a difference in lesion volumes when comparing those patients that had presenting symptoms of visual changes or balance symptoms with those presenting with sensory changes. Conclusions: This study supports the notion that presenting symptoms are not associated with EDSS independent disease duration. It also verifies that severity of disease is not associated with lesion volumes. However, sensory symptoms as a presenting symptom was associated with less lesion volumes in our study. MDPI 2021-01-08 /pmc/articles/PMC7838821/ /pubmed/33430058 http://dx.doi.org/10.3390/neurolint13010002 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Ledesma, Jason
Puttagunta, Padma Priya
Torabi, Shayan
Berube, Kristen
Tamrazian, Eric
Garcia, Diamond
Mehta, Bijal Kirit
Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
title Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
title_full Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
title_fullStr Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
title_full_unstemmed Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
title_short Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
title_sort presenting symptoms and disease severity in multiple sclerosis patients
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838821/
https://www.ncbi.nlm.nih.gov/pubmed/33430058
http://dx.doi.org/10.3390/neurolint13010002
work_keys_str_mv AT ledesmajason presentingsymptomsanddiseaseseverityinmultiplesclerosispatients
AT puttaguntapadmapriya presentingsymptomsanddiseaseseverityinmultiplesclerosispatients
AT torabishayan presentingsymptomsanddiseaseseverityinmultiplesclerosispatients
AT berubekristen presentingsymptomsanddiseaseseverityinmultiplesclerosispatients
AT tamrazianeric presentingsymptomsanddiseaseseverityinmultiplesclerosispatients
AT garciadiamond presentingsymptomsanddiseaseseverityinmultiplesclerosispatients
AT mehtabijalkirit presentingsymptomsanddiseaseseverityinmultiplesclerosispatients